LifeMD, Inc.

LifeMD, Inc. is a publicly traded direct-to-patient telehealth company that delivers comprehensive virtual and in-home healthcare services across the United States. The company connects subscribers with licensed doctors and nurse practitioners for virtual medical consultations, personalized treatment plans, and prescription medications. Its mission is to empower individuals to live healthier lives by increasing access to high-quality and affordable virtual and in-home healthcare. Headquartered in New York, NY, the company was founded in 1994 as ImmuDyne, Inc., later rebranded as Conversion Labs, Inc. in 2018, and adopted the LifeMD name in 2020 or February 2021.

LifeMD offers a wide array of services, including primary care, urgent care, chronic disease management, and specialty care through its proprietary technology platform. Key offerings and brands include men's health (Rex MD), women's health, weight management (featuring GLP-1 medications like Wegovy and Zepbound), dermatology (CleardMD, NavaMD), mental health, and cardiovascular health. Services are primarily offered on a subscription basis and include virtual consultations, lab testing, and prescription delivery. The company's direct-to-consumer model aims to make healthcare more accessible and convenient for patients nationwide.

Under the leadership of CEO and Chairman Justin Schreiber, LifeMD has strategically focused on high-demand specialty categories, particularly chronic conditions and weight management. Recent developments include partnerships with Eli Lilly (Foundayo) and Novo Nordisk (Wegovy) to offer GLP-1 medications, and the acquisition of Optimal Human Health MD in April 2025 to expand its women's health services. The company has also divested its majority interest in WorkSimpli to concentrate on its core virtual care and pharmacy platform. LifeMD reported strong revenue growth in 2025 and Q1 2025, alongside improved adjusted EBITDA, and has introduced private health insurance acceptance in 2024. As of late April 2026, LifeMD maintains a market capitalization ranging from approximately $212.5 million to $239.87 million.